Montelukast Sodium does not usually cause high urinary protein, this product may cause adverse reactions such as enuresis in children, and should be used in accordance with medical advice.
The commonly used dosage form of montelukast sodium is tablet. Its adverse reactions include upper respiratory tract infection, bleeding tendency, allergic reaction, aggressive behavior, depression, anxiety, inattention, hallucinations, insomnia, abnormal night dreams, psychomotor over-excitement, dizziness, somnolence, palpitations, diarrhea, nausea, elevated transaminases, and enuresis in children. Therefore, this product generally does not cause elevated urine protein.
Causes of elevated proteinuria include physiological factors such as strenuous exercise, Nutcracker syndrome, etc.; pathologic factors include nephritis, urinary tract infections, urinary stones, etc.
Montelukast is indicated for the prevention and long-term treatment of asthma in children over 2 years of age and for the relief of symptoms caused by allergic rhinitis. The drug is contraindicated in people who are allergic to the components of the product. The drug should be used rationally under the supervision of a doctor.
At the same time, it is recommended that patients with elevated urinary protein consult a regular hospital in a timely manner, improve the relevant examinations under the guidance of a physician, and carry out standardized treatment.